Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology - 1 Dec 2008

Kwon Jun Soo, Kim Euitae, Kang Do-Hyung, Choi Jung Seok, Yu Kyung-Sang, Jang In-Jin, Shin Sang-Goo

Abstract excerpt

We investigated whether the clinical response to aripiprazole differed according to the Taq1A polymorphism in the dopamine D2 receptor (DRD2) gene. In this 26-week, prospective, open-label, double-blind, parallel-group study, 90 patients with schizophrenia, schizoaffective disorder, or schizophreniform disorder were recruited and divided into two groups according to their DRD2 genotype (A1A1, n=14; A1A2+A2A2,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antidepressive Agents
Share to Antipsychotic Agents

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Double-Blind Method

Share to Prolactin

Share to Psychiatric Status Rating Scales

Share to Psychotic Disorders

Share to Quinolones

Share to Receptors, Dopamine D2

Source

Identifiers

PMID: 18786813
DOI: 10.1016/j.euroneuro.2008.07.010

Genes

DRD2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Taq1A polymorphism in the dopamine D2 receptor gene as a predictor of clinical response to aripiprazole.PMID 18786813Read ↗

Effects of DRD2/ANKK1 gene variations and clinical factors on aripiprazole efficacy in schizophrenic patients.Semantic proximity Read ↗

Effects of aripiprazole and the Taq1A polymorphism in the dopamine D2 receptor gene on the clinical response and plasma monoamine metabolites level during the acute phase of schizophrenia.Semantic proximity Read ↗

Dopamine D2 receptor gene polymorphisms predict well the response to dopamine antagonists at therapeutic dosages in patients with schizophrenia.Semantic proximity Read ↗

Association of a Schizophrenia Risk Variant at the DRD2 Locus With Antipsychotic Treatment Response in First-Episode Psychosis.Semantic proximity Read ↗

D2 receptor genetic variation and clinical response to antipsychotic drug treatment: a meta-analysis.Semantic proximity Read ↗

Antipsychotic drug—aripiprazole against schizophrenia, its therapeutic and metabolic effects associated with gene polymorphismsSemantic proximity Read ↗

Association between neuroleptic drug-induced extrapyramidal symptoms and dopamine D2-receptor polymorphisms in Japanese schizophrenic patients.Semantic proximity Read ↗

Association of TaqI A polymorphism of dopamine D2 receptor gene and tardive dyskinesia in schizophrenia.Semantic proximity Read ↗

The relationship between the therapeutic response to risperidone and the dopamine D2 receptor polymorphism in Chinese schizophrenia patients.Semantic proximity Read ↗

No influence of DTNBP1 polymorphisms on the response to aripiprazole.Semantic proximity Read ↗

Effects of the DRD3 Ser9Gly polymorphism on aripiprazole efficacy in schizophrenic patients as modified by clinical factors.Semantic proximity Read ↗

The relationship between dopamine D2 receptor polymorphism at the Taq1 A locus and therapeutic response to nemonapride, a selective dopamine antagonist, in schizophrenic patients.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.